rvu120,gilteritinib
astellas,ryvu therapeutics
['gilteritinib', 'hodgkin', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'lymphoma', 'multiple myeloma', 'rvu120 ', 'mds', 'ryvutx']
bonjour from new orleans! we are on-site at #ash22 to present, e.g., the updated data from the ongoing dose-escalation phase 1b trial of #rvu120 in aml and hr-mds, demonstrating clinical activity as monotherapy. read more: #discoverforpatients 
Ryvu Therapeutics is developing novel small molecule therapies that address clinical limitations of current treatments in oncology.